XML 33 R23.htm IDEA: XBRL DOCUMENT v3.23.1

Summary of Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2023

Summary of Significant Accounting Policies

Schedule of roll-forward of the allowance for credit losses

​

​	​	​	​
Balance at January 1, 2023		$	1,275
Change in expected credit losses	​		(103)
Write-offs, net of recoveries	​	​	(40)
Balance at March 31, 2023	​	$	1,132

​

Schedule of disaggregation of revenue by major markets

The following table disaggregates our revenues by major markets for the three months ended March 31, 2023 and 2022 (in thousands):

​

​	​	​	​	​	​	​
​	​	Three Months Ended
​	​	March 31,
​		2023			2022
Biopharma/Pharma	​	$	51,122	​	$	43,011
Animal Health	​		8,863	​	​	6,794
Reproductive Medicine	​	​	2,832	​	​	2,497
Total revenues	​	$	62,817	​	$	52,302

​

Schedule of geographical revenues, by origin

Our geographical revenues, by origin, for the three months ended March 31, 2023 and 2022, were as follows (in thousands):

​

​	​	​	​	​	​	​
​	​	Three Months Ended
​	​	March 31,
​		2023			2022
Americas	​	$	33,617	​	$	27,878
Europe, the Middle East and Africa (EMEA)	​		18,159	​	​	16,187
Asia Pacific (APAC)	​		11,041	​	​	8,237
Total revenues	​	$	62,817	​	$	52,302

​

Schedule of net loss per share

The following shows the amounts used in computing net loss per share (in thousands except per share data):

​

​	​	​	​	​	​	​
​	​	Three Months Ended March 31,
​		2023			2022
Net loss	​	$	(5,574)	​	$	(13,404)
Paid-in-kind dividend on Series C convertible preferred stock	​	​	(2,000)	​	​	(2,000)
Net loss attributable to common shareholders	​	$	(7,574)	​	$	(15,404)
Weighted average common shares outstanding - basic and diluted	​	​	48,362,501	​	​	49,660,579
Net loss per share attributable to common stockholders - basic and diluted	​	$	(0.16)	​	$	(0.31)

​

Schedule of number of shares excluded from the computation of diluted loss per share

​

​	​	​	​	​
​	​	Three Months Ended March 31,
​		2023		2022
Stock options	​	3,438,314	​	4,699,476
Restricted stock units	​	665,110	​	693,887
Series C convertible preferred stock	​	5,721,177	​	5,497,939
Convertible Senior Notes	​	4,022,734	​	4,022,734
​	​	13,847,335	​	14,914,036

​

X

- References

No definition available.

+ Details

Name:	us-gaap_AccountingPoliciesAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045

+ Details

Name:	us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph a
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599

+ Details

Name:	us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.3,4)
-URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

+ Details

Name:	us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257

+ Details

Name:	us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257

+ Details

Name:	us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration